Laura Aponte Becerra, MD. (@lauraapontebe) 's Twitter Profile
Laura Aponte Becerra, MD.

@lauraapontebe

Nephrology Critical Care fellow @YaleNephrology @YalePCCSM via @UmjmhIMRes @harvardmed @UniversidadCES | Proud 🇨🇴

ID: 1520575326572761088

calendar_today01-05-2022 01:26:31

49 Tweet

186 Followers

113 Following

Yale Nephrology (@yalenephrology) 's Twitter Profile Photo

Many treats this AM on another interview Friday: Dr. B’s (👑Ursula Brewster) favorite, Lithuanian coffee cake from Claire's CornerCopia, for her birthday from the fellows (👏Emily Moss for organizing!), & Anna Qian presenting a phenomenal talk on immune dysfunction in ESKD!

Yale Nephrology (@yalenephrology) 's Twitter Profile Photo

2nd year Neph-crit care fellow Laura Aponte Becerra, MD. flew across the 🌎 from her global health rotation in Uganda to American Society of Nephrology in San Diego to present her case with Deepthi Gunasekaran at #KidneyWk - Influenza B triggering aHUS in a patient w/ CBC disease carrier state + CFH mutation!

2nd year Neph-crit care fellow <a href="/LauraAponteBe/">Laura Aponte Becerra, MD.</a> flew across the 🌎 from her global health rotation in Uganda to <a href="/ASNKidney/">American Society of Nephrology</a> in San Diego to present her case with <a href="/DeepthiGunasek1/">Deepthi Gunasekaran</a> at #KidneyWk - Influenza B triggering aHUS in a patient w/ CBC disease carrier state + CFH mutation!
Oscar Garcia, MD (@oscargarciamd) 's Twitter Profile Photo

Thanks to American Society of Nephrology for another amazing #KidneyWk and for the opportunity to share our research. It was a wonderful experience to reconnect with old friends, meet new ones, and learn from leading experts in the field. Especial thanks to Mayo Clinic Nephrology for making it possible.

Thanks to <a href="/ASNKidney/">American Society of Nephrology</a> for another amazing #KidneyWk and for the opportunity to share our research.

It was a wonderful experience to reconnect with old friends, meet new ones, and learn from leading experts in the field.

Especial thanks to <a href="/MayoClinicNeph/">Mayo Clinic Nephrology</a> for making it possible.
Yale Nephrology (@yalenephrology) 's Twitter Profile Photo

Special congratulations to our 2nd year Nephrology fellows Saad Alshihri and Adrian Llama for matching into Yale CC fellowship!! Along with Laura Aponte Becerra, MD., there is a lot of Neph Crit Care representation here at Yale PCCSM ! Ursula Brewster Arundati Rao Yale Internal Medicine

Yale Nephrology (@yalenephrology) 's Twitter Profile Photo

Dr. Laura Aponte Becerra, MD. used Renal Rounds this AM to share with us her reflections & takeaways from her fellowship experience as a Global Health @ Yale scholar in Uganda this year! So grateful for our partnership with Makerere University Makerere University Hospital making impactful experiences like this possible!

Dr. <a href="/LauraAponteBe/">Laura Aponte Becerra, MD.</a> used Renal Rounds this AM to share with us her reflections &amp; takeaways from her fellowship experience as a <a href="/YaleGH/">Global Health @ Yale</a> scholar in Uganda this year! 

So grateful for our partnership with <a href="/Makerere/">Makerere University</a> <a href="/MakerereHosp/">Makerere University Hospital</a> making impactful experiences like this possible!
F. Perry Wilson, MD MSCE (@fperrywilson) 's Twitter Profile Photo

This week, I've been thinking about pain. And David Lynch. The former, because of a very cool study in @JAMANeurology which I'll tell you about in a second. The latter because Dune 1984 and Twin Peaks were transformative to my childhood. (Thread)

F. Perry Wilson, MD MSCE (@fperrywilson) 's Twitter Profile Photo

The GLP-1 receptor agonists (like Ozempic and Mounjaro) are wildly effective weight-loss agents. But are they COST-effective? That's a trickier question. And a new study just out in JAMA Health Forum provides an answer. A resounding "no." (Thread)

The GLP-1 receptor agonists (like Ozempic and Mounjaro) are wildly effective weight-loss agents. But are they COST-effective?  That's a trickier question. And a new study just out in JAMA Health Forum provides an answer. A resounding "no."  
(Thread)